Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 93 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 7402299

    Intracorporeal medicaments for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

  2. US 7390668

    Intracorporeal medicaments for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jun 24, 2008 · Expires Jun 19, 2028

    granted

  3. US 7387881

    Detection and treatment of cancers of the liver

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 17, 2008 · Expires Jun 12, 2028

    granted

  4. US 7384909

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents

    The Board of Regents of the University of Texas System · Granted Jun 10, 2008 · Expires Jun 5, 2028

    granted

  5. US 7381404

    Treatment for dry macular degeneration

    The Regents of the University of California · Granted Jun 3, 2008 · Expires May 29, 2028

    granted

  6. US 7381405

    Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 3, 2008 · Expires May 29, 2028

    granted

  7. US 7378386

    Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives

    The Board of Regents of the University of Texas System · Granted May 27, 2008 · Expires May 22, 2028

    granted

  8. US 7374752

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted May 20, 2008 · Expires May 15, 2028

    granted

  9. US 7368106

    Use of a promoter of T-cell expansion and an inducer of CD40 stimulation in the treatment or prevention of a pathologic state

    The United States of America, as represented by the Department of Health and Human Services · Granted May 6, 2008 · Expires May 1, 2028

    granted

  10. US 7364726

    Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine

    The Regents of the University of California · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted

  11. US 7361680

    Indole compounds useful for the treatment of cancer

    The Regents of the University of California · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted

  12. US 7354580

    Method of administering and using VEGF inhibitors for the treatment of human cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted

  13. US 7354582

    Use of VEGF antagonists for the treatment of malignant gliomas

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted

  14. US 7354900

    Treatment and inhibition of ocular infections and wounds by CAP37 and CAP37 peptides

    The Board of Regents of the University of Oklahoma · Granted Apr 8, 2008 · Expires Apr 3, 2028

    granted

  15. US 7344829

    Methods for detecting the efficacy of anticancer treatments

    The Board of Regents of the University of Texas System · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted

  16. US 7345030

    Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals

    Third Military Medical University, Chinese People's Liberation Army, P.R. of China · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted

  17. US 7344711

    Use of adenoviruses mutated in the VA genes for cancer treatment

    ONCOLYTICS BIOTECH INC. · Granted Mar 18, 2008 · Expires Mar 13, 2028

    granted

  18. US 7335640

    Administration of hypocretin-1 for treatment of narcolepsy

    The Regents of the University of California · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted

  19. US 7335382

    Compositions and methods for the treatment and prevention of cancer

    Northwestern University · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted

  20. US 7326734

    Treatment of bladder and urinary tract cancers

    The Regents of the University of California · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted

  21. US 7309483

    Method of treatment using Tie2 ligand2

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted

  22. US 7306799

    Use of VEGF inhibitors for treatment of eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 11, 2007 · Expires Dec 6, 2027

    granted

  23. US 7303747

    Use of VEGF inhibitors for treatment of eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted

  24. US 7300915

    Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain

    The Regents of the University of California · Granted Nov 27, 2007 · Expires Nov 22, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.